title: Hepatitis C as a prognostic indicator among noncirrhotic patients hospitalized with alcoholic hepatitis.
abstract: OBJECTIVE
  A nationwide analysis of alcoholic hepatitis (AH) admissions was conducted to determine the impact of hepatitis C virus (HCV) infection on short-term survival and hospital resource utilization.
  
  
  METHODS
  Using the Nationwide Inpatient Sample, noncirrhotic patients admitted with AH throughout the United States between 1998 and 2006 were identified with diagnostic codes from the International Classification of Diseases, Ninth Revision. The in-hospital mortality rate (primary end point) of AH patients with and without co-existent HCV infection was determined. Hospital resource utilization was assessed as a secondary end point through linear regression analysis.
  
  
  RESULTS
  From 1998 to 2006, there were 112,351 admissions for AH. In-hospital mortality was higher among patients with coexistent HCV infection (41.1% versus 3.2%; P=0.07). The adjusted odds of in-hospital mortality in the presence of HCV was 1.48 (95% CI 1.10 to 1.98). Noncirrhotic patients with AH and HCV also had longer length of stay (5.8 days versus 5.3 days; P<0.007) as well as greater hospital charges (US$25,990 versus US$21,030; P=0.0002).
  
  
  CONCLUSIONS
  Among noncirrhotic patients admitted with AH, HCV infection was associated with higher in-hospital mortality and resource utilization.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Thuluvath
authors.forename: Eric
authors.initials: E
authors.lastname: Ahn
authors.forename: Geoffrey C
authors.initials: GC
authors.lastname: Nguyen
mesh_terms: D000328:Adult; D005260:Female; D006526:Hepatitis C / Q000191:economics / Q000453:epidemiology* / Q000401:mortality; D006519:Hepatitis, Alcoholic / Q000191:economics / Q000401:mortality / Q000821:virology*; D017722:Hospital Charges; D017052:Hospital Mortality; D006760:Hospitalization / Q000191:economics / Q000706:statistics & numerical data*; D006801:Humans; D007902:Length of Stay; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D015996:Survival Rate; D014481:United States / Q000453:epidemiology
references.citation: N Engl J Med. 2009 Jun 25;360(26):2758-69
references.pmid: 19553649
references.citation: J Clin Gastroenterol. 2007 Sep;41(8):761-72
references.pmid: 17700425
references.citation: J Clin Epidemiol. 1992 Jun;45(6):613-9
references.pmid: 1607900
references.citation: Semin Liver Dis. 2009 May;29(2):188-99
references.pmid: 19387918
references.citation: Semin Liver Dis. 2004 Aug;24(3):305-15
references.pmid: 15349807
references.citation: J Chronic Dis. 1987;40(5):373-83
references.pmid: 3558716
references.citation: Med Care. 2005 Nov;43(11):1130-9
references.pmid: 16224307
references.citation: Eur J Gastroenterol Hepatol. 2011 Mar;23(3):204-9
references.pmid: 21258239
references.citation: Aliment Pharmacol Ther. 2009 Jul;30(1):3-13
references.pmid: 19416132
references.citation: J Clin Epidemiol. 1994 Nov;47(11):1245-51
references.pmid: 7722560
references.citation: Med Clin North Am. 2008 Jul;92(4):795-812, viii
references.pmid: 18570943
references.citation: Clin Gastroenterol Hepatol. 2004 Oct;2(10):928-34
references.pmid: 15476157
references.citation: J Hepatol. 2011 Apr;54(4):760-4
references.pmid: 21126790
references.citation: Lancet. 2010 Jul 17;376(9736):190-201
references.pmid: 20638564
references.citation: Hepatology. 2007 Jun;45(6):1348-54
references.pmid: 17518367
references.citation: Hepatology. 2005 Feb;41(2):353-8
references.pmid: 15660383
references.citation: JAMA. 2004 Mar 10;291(10):1238-45
references.pmid: 15010446
references.citation: Scand J Gastroenterol. 2003 Aug;38(8):864-70
references.pmid: 12940441
references.citation: J Clin Gastroenterol. 2011 Sep;45(8):714-9
references.pmid: 21085006
references.citation: Gastroenterology. 1978 Aug;75(2):193-9
references.pmid: 352788
references.citation: J Hepatol. 2005 May;42(5):700-6
references.pmid: 15826720